The Trump administration’s top Medicare official used an annual report on the program’s fiscal outlook to attack proposals by some Democrats to expand government health-care coverage to all Americans.
UnitedHealth Group has been a stock market darling for much of the past decade, dependably churning out earnings increases and rewarding shareholders with staggering returns.
For a patient’s knee replacement, Medicare will pay a hospital $17,000. The same hospital can get more than twice as much, or about $37,000, for the same surgery on a patient with private insurance.
Affordable health care continues to be an important concern of Americans. Many Democrats are advocating “Medicare for All” as a solution, although the details of a Medicare for All system are still being developed and it’s unclear whether a proposal can be developed that all Democrats would support.
Medicare's hospital insurance fund will be depleted in 2026, as previously forecast, and Social Security program costs are likely to exceed total income in 2020 for the first time since 1982, according to a government report released on Monday.
The Centers for Medicare and Medicaid Services (CMS) has finished setting the rules and numbers health insurers need to design the individual commercial major medical insurance policies for 2020.
Large drug makers and the industry’s primary trade group neared previous spending records on lobbying in the first three months of the year as President Donald Trump and Congress increased pressure to rein in the cost of medicine.
CMS is taking aim at increasing the use of generic drugs in ACA plans in a new rule filed Thursday evening.
The White House and top lawmakers from both parties think a bill to lower drug prices has a better chance of becoming law before the 2020 election than any other controversial legislation.
The CMS finalized a rule on Thursday that would allow health insurers to implement copay accumulator programs to prevent drug manufacturer coupons from applying to a patient's annual limit on out-of-pocket costs in situations where a generic drug is available.